Literature DB >> 18434132

Patient demographics and lifestyle factors influencing long-term survival of oesophageal cancer and gastric cardia cancer in a nationwide study in Sweden.

Martin Sundelöf1, Jesper Lagergren, Weimin Ye.   

Abstract

BACKGROUND: Little is known about the possible influence of demographic and aetiologic risk factors on the survival amongst patients with oesophageal and cardia cancer.
METHODS: In a Swedish nationwide case-control study conducted in 1995-1997, 618 patients diagnosed with oesophageal or cardia cancer were interviewed regarding demographic and lifestyle factors, and followed up for survival through a 2004. Information about the treatment was collected through review of medical records, and 38 patients with missing records were excluded. Survival curves were estimated by Kaplan-Meier method. Cox proportional hazards regression models were used to derive hazard ratios (HRs) and 95% confidence intervals (CIs), with adjustment for known or suspected prognostic factors.
RESULTS: Amongst the 580 included patients, 177 had oesophageal adenocarcinoma, 159 oesophageal squamous-cell carcinoma and 244 had cardia adenocarcinoma. Surgical resection was conducted in 224 patients (39%). The overall 5-year survival rate was 12%. Amongst patients with oesophageal adenocarcinoma, obese patients had a favourable prognosis compared to those of normal weight (HR=0.6, 95%CI 0.3-1.0). Amongst patients with oesophageal squamous-cell carcinoma, lean patients had a better prognosis (HR=0.6, 95%CI 0.4-1.0), whilst previous smokers (HR=2.1, 95%CI 1.0-4.4) and low educated (HR=1.9, 95%CI 1.1-3.4) had a worse prognosis. There were no statistically significant associations between sex, age, reflux symptoms, alcohol consumption or physical activity and prognosis in any of the three studied cancer subtypes.
CONCLUSIONS: Body mass, tobacco smoking and education might influence the long-term survival of patients with oesophageal cancer.

Entities:  

Mesh:

Year:  2008        PMID: 18434132     DOI: 10.1016/j.ejca.2008.04.002

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  26 in total

Review 1.  Mitigating the adverse health effects and costs associated with smoking after a cancer diagnosis.

Authors:  Graham W Warren
Journal:  Transl Lung Cancer Res       Date:  2019-05

2.  Prediagnostic smoking and postoperative survival in lymph node-negative esophagus squamous cell carcinoma patients.

Authors:  Yongbin Lin; Xiaodong Su; Hongyu Su; Peng Lin; Hao Long; Lanjun Zhang; Jianhua Fu; Tiehua Rong; Zihui Tan; Yuqi Meng; Guowei Ma
Journal:  Cancer Sci       Date:  2012-10-09       Impact factor: 6.716

3.  Combined modality therapy of cT2N0M0 esophageal cancer: the University of Texas M. D. Anderson Cancer Center experience.

Authors:  Panteleimon Kountourakis; Arlene M Correa; Wayne L Hofstetter; Jeffrey H Lee; Manoop S Bhutani; David C Rice; Ritsuko Komaki; Dipen M Maru; William A Ross; Ara Vaporciyan; Stephen G Swisher; Jaffer A Ajani
Journal:  Cancer       Date:  2010-10-19       Impact factor: 6.860

4.  Prognostic impact of body mass index stratified by smoking status in patients with esophageal adenocarcinoma.

Authors:  Harry H Yoon; Mark A Lewis; Qian Shi; Maliha Khan; Stephen D Cassivi; Robert B Diasio; Frank A Sinicrope
Journal:  J Clin Oncol       Date:  2011-10-11       Impact factor: 44.544

5.  The columnar-lined mucosa at the gastroesophageal junction in non-human primates.

Authors:  Carlos A Rubio; Edward J Dick; Natalia E Schlabritz-Loutsevitch; Abiel Orrego; Gene B Hubbard
Journal:  Int J Clin Exp Pathol       Date:  2008-01-20

6.  MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival.

Authors:  Ewy A Mathé; Giang Huong Nguyen; Elise D Bowman; Yiqiang Zhao; Anuradha Budhu; Aaron J Schetter; Rosemary Braun; Mark Reimers; Kensuke Kumamoto; Duncan Hughes; Nasser K Altorki; Alan G Casson; Chang-Gong Liu; Xin Wei Wang; Nozomu Yanaihara; Nobutoshi Hagiwara; Andrew J Dannenberg; Masao Miyashita; Carlo M Croce; Curtis C Harris
Journal:  Clin Cancer Res       Date:  2009-09-29       Impact factor: 12.531

7.  Prognostic influence of smoking on esophageal squamous cell carcinoma.

Authors:  Nana Wang; Bingxu Tan; Fangli Cao; Qingxu Song; Jianbo Wang; Yibin Jia; Yufeng Cheng
Journal:  Int J Clin Exp Med       Date:  2015-10-15

8.  Prognostic factors for esophageal squamous cell carcinoma--a population-based study in Golestan Province, Iran, a high incidence area.

Authors:  Karim Aghcheli; Haji-Amin Marjani; Dariush Nasrollahzadeh; Farhad Islami; Ramin Shakeri; Masoud Sotoudeh; Behnoush Abedi-Ardekani; Mohammad-Reza Ghavamnasiri; Ezzatollah Razaei; Elias Khalilipour; Samira Mohtashami; Yasha Makhdoomi; Rabea Rajabzadeh; Shahin Merat; Rasoul Sotoudehmanesh; Shahryar Semnani; Reza Malekzadeh
Journal:  PLoS One       Date:  2011-07-21       Impact factor: 3.240

9.  Diverging trends in recent population-based survival rates in oesophageal and gastric cancer.

Authors:  Jesper Lagergren; Fredrik Mattsson; Fredrik Mattson
Journal:  PLoS One       Date:  2012-07-18       Impact factor: 3.240

10.  Substance use (alcohol, areca nut and cigarette) is associated with poor prognosis of esophageal squamous cell carcinoma.

Authors:  I-Chen Wu; Chun-Chieh Wu; Chien-Yu Lu; Wen-Hung Hsu; Meng-Chieh Wu; Jui-Ying Lee; Shah-Hwa Chou; Jang-Ming Lee; Yi-Ping Chou; Deng-Chyang Wu; Ming-Tsang Wu
Journal:  PLoS One       Date:  2013-02-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.